Suzhou, China

Qianlei Yang

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qianlei Yang: Innovator in Carcinogenic Research

Introduction

Qianlei Yang is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of carcinogenic research, particularly in understanding the effects of arsenic on human keratinocytes. His innovative work has led to the development of a unique cell model that aids in the study of cancer mechanisms.

Latest Patents

Yang holds a patent titled "Dimethylarsinous acid-induced malignantly transformed cell line of human keratinocytes and use thereof." This invention relates to the establishment of a model that demonstrates how persistent exposure to dimethylarsinous acid can lead to malignant transformations in skin cells. The patent highlights the importance of this model in identifying the carcinogenicity of arsenic methylated metabolites, providing a new basis for research into the carcinogenic mechanisms of arsenic.

Career Highlights

Qianlei Yang is affiliated with Soochow University, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential implications in cancer research and public health.

Collaborations

Yang collaborates with notable colleagues, including Yan An and Rui Yan, who contribute to his research endeavors. Their combined expertise enhances the quality and impact of their work in the field.

Conclusion

Qianlei Yang's innovative research and patent contributions significantly advance our understanding of carcinogenic processes related to arsenic exposure. His work not only provides valuable insights into cancer mechanisms but also establishes a foundation for future research in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…